Borer Denton & Associates, Inc. Novo Nordisk A S Transaction History
Borer Denton & Associates, Inc.
- $288 Billion
- Q4 2024
A detailed history of Borer Denton & Associates, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Borer Denton & Associates, Inc. holds 113,181 shares of NVO stock, worth $8.7 Million. This represents 3.39% of its overall portfolio holdings.
Number of Shares
113,181
Previous 114,472
1.13%
Holding current value
$8.7 Million
Previous $13.6 Billion
28.57%
% of portfolio
3.39%
Previous 4.65%
Shares
10 transactions
Others Institutions Holding NVO
# of Institutions
1,885Shares Held
336MCall Options Held
11.9MPut Options Held
10.6M-
Jennison Associates LLC19.9MShares$1.53 Billion1.06% of portfolio
-
Bank Of America Corp Charlotte, NC15.5MShares$1.19 Billion0.11% of portfolio
-
Gqg Partners LLC Ft. Lauderdale, FL13MShares$999 Million1.67% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa12.6MShares$972 Million0.44% of portfolio
-
Morgan Stanley New York, NY12.2MShares$938 Million0.08% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $173B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...